These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 8709234)
21. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Sheehy AM; Gaddis NC; Choi JD; Malim MH Nature; 2002 Aug; 418(6898):646-50. PubMed ID: 12167863 [TBL] [Abstract][Full Text] [Related]
22. Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription. Henriet S; Sinck L; Bec G; Gorelick RJ; Marquet R; Paillart JC Nucleic Acids Res; 2007; 35(15):5141-53. PubMed ID: 17660191 [TBL] [Abstract][Full Text] [Related]
23. Role of Vif in stability of the human immunodeficiency virus type 1 core. Ohagen A; Gabuzda D J Virol; 2000 Dec; 74(23):11055-66. PubMed ID: 11070000 [TBL] [Abstract][Full Text] [Related]
24. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Schäfer A; Bogerd HP; Cullen BR Virology; 2004 Oct; 328(2):163-8. PubMed ID: 15464836 [TBL] [Abstract][Full Text] [Related]
25. Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. Courcoul M; Patience C; Rey F; Blanc D; Harmache A; Sire J; Vigne R; Spire B J Virol; 1995 Apr; 69(4):2068-74. PubMed ID: 7884852 [TBL] [Abstract][Full Text] [Related]
26. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. Dettenhofer M; Yu XF J Virol; 1999 Feb; 73(2):1460-7. PubMed ID: 9882352 [TBL] [Abstract][Full Text] [Related]
27. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein. Liu H; Wu X; Xiao H; Conway JA; Kappes JC J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854 [TBL] [Abstract][Full Text] [Related]
28. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif. Feng F; Davis A; Lake JA; Carr J; Xia W; Burrell C; Li P J Virol; 2004 Oct; 78(19):10574-81. PubMed ID: 15367624 [TBL] [Abstract][Full Text] [Related]
29. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Arrigo SJ; Chen IS Genes Dev; 1991 May; 5(5):808-19. PubMed ID: 1827422 [TBL] [Abstract][Full Text] [Related]
30. Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. Bouyac M; Rey F; Nascimbeni M; Courcoul M; Sire J; Blanc D; Clavel F; Vigne R; Spire B J Virol; 1997 Mar; 71(3):2473-7. PubMed ID: 9032385 [TBL] [Abstract][Full Text] [Related]
31. The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. Kao S; Khan MA; Miyagi E; Plishka R; Buckler-White A; Strebel K J Virol; 2003 Nov; 77(21):11398-407. PubMed ID: 14557625 [TBL] [Abstract][Full Text] [Related]
32. Functional domains of APOBEC3G required for antiviral activity. Li J; Potash MJ; Volsky DJ J Cell Biochem; 2004 Jun; 92(3):560-72. PubMed ID: 15156567 [TBL] [Abstract][Full Text] [Related]
33. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA. Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319 [TBL] [Abstract][Full Text] [Related]
34. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. Karczewski MK; Strebel K J Virol; 1996 Jan; 70(1):494-507. PubMed ID: 8523563 [TBL] [Abstract][Full Text] [Related]
35. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. Gabuzda DH; Li H; Lawrence K; Vasir BS; Crawford K; Langhoff E J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):908-15. PubMed ID: 7519673 [TBL] [Abstract][Full Text] [Related]
36. Role of Vif in human immunodeficiency virus type 1 reverse transcription. Goncalves J; Korin Y; Zack J; Gabuzda D J Virol; 1996 Dec; 70(12):8701-9. PubMed ID: 8970997 [TBL] [Abstract][Full Text] [Related]
37. Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity. Ma XY; Sova P; Chao W; Volsky DJ J Virol; 1994 Mar; 68(3):1714-20. PubMed ID: 8107232 [TBL] [Abstract][Full Text] [Related]
38. A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. Guy B; Geist M; Dott K; Spehner D; Kieny MP; Lecocq JP J Virol; 1991 Mar; 65(3):1325-31. PubMed ID: 1995946 [TBL] [Abstract][Full Text] [Related]
39. The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells. Wang J; Shackelford JM; Casella CR; Shivers DK; Rapaport EL; Liu B; Yu XF; Finkel TH Virology; 2007 Mar; 359(2):243-52. PubMed ID: 17056089 [TBL] [Abstract][Full Text] [Related]
40. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: functional difference between Vif and Nef. Akari H; Uchiyama T; Fukumori T; Iida S; Koyama AH; Adachi A J Gen Virol; 1999 Nov; 80 ( Pt 11)():2945-2949. PubMed ID: 10580056 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]